ArticleDermatology reports2022

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema.

Nicoletta Bernardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.